Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment The State of the Science, Evaluation, Implementation, and Economics: Workshop Summary (2006) / Chapter Skim
Currently Skimming:
Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants
Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants
Pages 99-102
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 99... ...
Suresh Arya, National Institutes of Health Finley Austin, Roche Pharmaceuticals Rekha Ayalur, Digene Corporation Chris Beecher, Metabolon Al Berg, University of Washington* Amy Brownawell, Life Sciences Research Office Johanna Camara, National Institute of Standards and Technology Jacek Capala, National Cancer Institute David Carbone, Vanderbilt University Brian Carey, Foley Hoag LLP B
|
From page 100... ...
Judith Hellerstein, University of Maryland Ronald Hendrickson, Merck and Co., Inc. Stuart Hogarth, University of Cambridge Janet Jamison, National Cancer Institute Gail Javitt, Genetics and Public Policy Center Carolyn Jones, Advanced Medical Technology Association (AdvaMed)
|
From page 101... ...
Scott Ramsey, Fred Hutchinson Cancer Research Center David Ransohoff, University of North Carolina* Eddie Reed, Centers for Disease Control and Prevention Laura Reid, Expression Analysis Henry Rodriguez, National Cancer Institute Jim Rollins, Centers for Medicare & Medicaid Services*
|
From page 102... ...
0 DEVELOPINGCANCERBIOMARKERS Brent Zanke, MD, Cancer Care Ontario Ann Zauber, Memorial Sloan-Kettering Cancer Center Claire Zhu, National Cancer Institute Piotr Zien, Advanced Medical Technology Association (AdvaMed)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.